COVA1-18

N/A

Report date: 2025/01/26 17:21:12

Base Information

Drug NameCOVA1-18
Drug Alias Nameneutralizing monoclonal antibody cocktail (Angany/Amsterdam UMC)COVA1-18
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcademic Medical Center University of Amsterdam
China Registration ClassN/A

Develop Information

Active CompaniesAcademic Medical Center University of AmsterdamAngany Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A